STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
Source ↗
👁 0
💬 0
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating. Now, though, that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance. You knew this would happen, yes? To cope, we are relying, as always, on a cup of stimulation. Our choice today is maple bourbon — a shot of salvation, so to speak. Feel free to join us. Remember, no prescription is required. Meanwhile, here are a few items of int
Comments (0)